Medpace Holdings Inc (MEDP) Stock Price, Quote & News

Company Profile

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical moni...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 513 579 9911

Fax: 513 579 0444

Website: www.medpace.com

Address:

5375 Medpace Way, Cincinnati, United States

MarketArchetypes Feb. 20 at 1:54 PM

$MEDP Medpace provides clinical research services. Revenue visibility depends on biotech R&D spending. High margins support valuation.

0 · Reply

high_tech_texan Feb. 18 at 2:43 PM

$MEDP That was scary ride, but I'm out with only a small loss.

0 · Reply

topstockalerts Feb. 13 at 4:47 PM

Jefferies upgraded Medpace to Buy, citing a rebound in biotech funding, a conservative balance sheet, and limited near-term AI risk as catalysts for a recovery in bookings and earnings. Biotech funding rose 56% in 2H25, with 4Q marking a record period. Given Medpace’s typical four- to six-quarter lag between funding and new awards, Jefferies expects bookings to accelerate in 2H26 and into 2027. Near-term orders may remain soft as the company laps weaker funding conditions from late 2024 and early 2025, but improving RFP activity and stabilizing cancellations point to a recovery later this year. The broker sees the book-to-bill ratio approaching ~1.20x by 4Q26. On AI, Jefferies said full-service CROs like Medpace face less immediate disruption than firms exposed to functional service provider models. AI adoption in clinical development is likely to take years to validate and scale, with smaller biotech clients focused more on execution than tech shifts. $MEDP

0 · Reply

medguy Feb. 12 at 3:33 PM

$MEDP I'm in

0 · Reply

1986iamwallstreet Feb. 12 at 2:37 PM

$MEDP 🩸🩸🩸🩸🩸🩸🩸

0 · Reply

LuizRec25 Feb. 11 at 3:14 PM

$MEDP any how, did my DD before, not doing strangle or stradle, just one leg (put), wven i dont like to do this. However many considerations, low volume kill me on the wait

0 · Reply

LuizRec25 Feb. 11 at 3:12 PM

$MEDP this could be the support, maybe goes to a $420, any way sold my $410 put for s small profit of $70

0 · Reply

LuizRec25 Feb. 11 at 9:44 AM

$MEDP $SNDK PUT options of $450, went up yesterday 100% from$0.73 to a $1,50 on a +-7% drop, over a 100 points away from the price. This $MEDP DROP 16% i had $410 put for next week, and went to $0,01, can some one explain why, other then volume ?

0 · Reply

d_risk Feb. 10 at 11:22 PM

$MEDP - Medpace Holdings Inc - 10K - Updated Risk Factors MEDP’s 2026 10-K risk factors shift from granular CRO, legal, tech, and insurance exposures toward broader structural, international, data privacy, and governance risks, while adding sharper focus on contract cancellations, backlog uncertainty, biopharma IP litigation, M&A consolidation, fixed-fee and Phase I liabilities, and disaster impacts. #ContractResearchOrganization #BacklogUncertainty #M&AConsolidation #BiopharmaLitigation #DataPrivacy 🟢 Added 🟠 Removed https://dev.d-risk.ai/MEDP/10-K/2026-02-10

0 · Reply

hunanddone Feb. 10 at 6:47 PM

$MEDP Anyone else hit it on that drop?!!! Up 6k in 5 minutes...got my toes in the water....

0 · Reply

Medpace Holdings Under Investigation After Book-to-Bill Miss Exposes Cancellation Surge and Pipeline Fragility

Feb 11, 2026, 2:00 AM EST - 15 days ago

Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial

Feb 10, 2026, 12:04 PM EST - 15 days ago

Medpace Holdings, Inc. (MEDP) Q4 2025 Earnings Call Transcript

Feb 9, 2026, 10:58 PM EST - 16 days ago

Medpace Holdings: Great Quarter, Stale Backlog, Full Valuation

Feb 9, 2026, 4:15 PM EST - 16 days ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results

Jan 5, 2026, 4:05 PM EST - 7 weeks ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 9, 2026

Nov 27, 2025, 9:11 AM EST - 3 months ago

Wasatch Global Opportunities Fund Q3 2025 Contributors And Detractors

FOUR MOD

Nov 18, 2025, 12:59 PM EST - 3 months ago

6 Healthcare Stocks With Strong Upward Momentum

ABVX CAH ELAN GH WGS

Oct 24, 2025, 9:55 AM EDT - 4 months ago

Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings

Oct 23, 2025, 4:52 PM EDT - 4 months ago

Medpace: Full CRO Model Builds Net Revenue Growth, Maintain At Strong Buy

Oct 23, 2025, 1:37 PM EDT - 4 months ago

Medpace Holdings, Inc. (MEDP) Q3 2025 Earnings Call Transcript

Oct 23, 2025, 12:00 PM EDT - 4 months ago

Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins

Oct 23, 2025, 11:15 AM EDT - 4 months ago

Medpace Holdings' Good Quarter Is Another Sign Biotech Is Back

Oct 22, 2025, 9:30 PM EDT - 4 months ago

Six Names, Six Narratives: Optimist Fund's Q3 Performance Map

CVNA FVRR TDUP W

Oct 22, 2025, 4:15 PM EDT - 4 months ago

Medpace Holdings, Inc. Reports Third Quarter 2025 Results

Sep 23, 2025, 4:05 PM EDT - 5 months ago

Medpace Holdings, Inc. to Report Third Quarter 2025 Financial Results on October 22, 2025

Sep 17, 2025, 5:14 AM EDT - 5 months ago

Medpace: Profit Margin, Growth, And Repurchase Program Will Trump Legislative Headwinds (Rating Upgrade)

Aug 4, 2025, 2:25 AM EDT - 7 months ago

Medpace: Return Of The Mack, With Double-Digit Revenue Growth

Jul 22, 2025, 2:14 PM EDT - 7 months ago

Medpace Holdings, Inc. (MEDP) Q2 2025 Earnings Call Transcript

Jul 22, 2025, 1:00 PM EDT - 7 months ago

Medpace's Global CRO Reach Lends Credibility For Its 2025 Revenue Guidance Increase

Jul 22, 2025, 7:36 AM EDT - 7 months ago

This Clinical Trials Stock Just Soared 40%. What Caused It to Pop.

Jul 22, 2025, 7:02 AM EDT - 7 months ago

Top 2 Health Care Stocks You May Want To Dump This Quarter

RXRX

Jul 21, 2025, 4:15 PM EDT - 7 months ago

Medpace Holdings, Inc. Reports Second Quarter 2025 Results

Jun 23, 2025, 4:05 PM EDT - 8 months ago

Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025

Apr 22, 2025, 3:42 PM EDT - 11 months ago

Medpace Holdings, Inc. (MEDP) Q1 2025 Earnings Call Transcript

Apr 21, 2025, 4:15 PM EDT - 11 months ago

Medpace Holdings, Inc. Reports First Quarter 2025 Results

Apr 4, 2025, 8:14 AM EDT - 11 months ago

Medpace Holdings: It Might Be Time To Buy In

Mar 18, 2025, 4:05 PM EDT - 1 year ago

Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025

Mar 1, 2025, 11:00 AM EST - 1 year ago

The Schall Law Firm Invites Shareholders With Losses In Medpace Holdings, Inc. To Join A Securities Fraud Investigation

Feb 11, 2025, 5:40 PM EST - 1 year ago

Medpace Holdings, Inc. (MEDP) Q4 2024 Earnings Call Transcript

Feb 10, 2025, 4:15 PM EST - 1 year ago

Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Results

Feb 5, 2025, 10:46 PM EST - 1 year ago

Medpace: Impressive Revenue Growth, High ROE Values, And High Growth Potential

Feb 2, 2025, 11:00 AM EST - 1 year ago

The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Medpace Holdings, Inc. For Securities Fraud

Jan 30, 2025, 11:00 AM EST - 1 year ago

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Jan 28, 2025, 11:00 AM EST - 1 year ago

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 24, 2025, 2:35 PM EST - 1 year ago

MoneyShow's Best Investment Ideas For 2025: Part 6

ALLY FTI OS PTON UAMY VRT

Jan 15, 2025, 1:15 PM EST - 1 year ago

Medpace Holdings Inc Is Being Investigated For Securities Fraud And Impacted Investors Are Urged To Contact The Schall Law Firm

Jan 8, 2025, 11:15 AM EST - 1 year ago

Medpace Holdings Inc Is Being Investigated For Securities Fraud And Affected Investors Are Urged To Contact The Schall Law Firm

Jan 2, 2025, 4:05 PM EST - 1 year ago

Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 10, 2025

Jan 2, 2025, 11:15 AM EST - 1 year ago

Medpace Holdings, Inc. Is Being Investigated For Securities Fraud And Investors With Losses Are Urged To Contact The Schall Law Firm

MarketArchetypes Feb. 20 at 1:54 PM

$MEDP Medpace provides clinical research services. Revenue visibility depends on biotech R&D spending. High margins support valuation.

0 · Reply

high_tech_texan Feb. 18 at 2:43 PM

$MEDP That was scary ride, but I'm out with only a small loss.

0 · Reply

topstockalerts Feb. 13 at 4:47 PM

0 · Reply

medguy Feb. 12 at 3:33 PM

$MEDP I'm in

0 · Reply

1986iamwallstreet Feb. 12 at 2:37 PM

$MEDP 🩸🩸🩸🩸🩸🩸🩸

0 · Reply

LuizRec25 Feb. 11 at 3:14 PM

$MEDP any how, did my DD before, not doing strangle or stradle, just one leg (put), wven i dont like to do this. However many considerations, low volume kill me on the wait

0 · Reply

LuizRec25 Feb. 11 at 3:12 PM

$MEDP this could be the support, maybe goes to a $420, any way sold my $410 put for s small profit of $70

0 · Reply

LuizRec25 Feb. 11 at 9:44 AM

0 · Reply

d_risk Feb. 10 at 11:22 PM

0 · Reply

hunanddone Feb. 10 at 6:47 PM

$MEDP Anyone else hit it on that drop?!!! Up 6k in 5 minutes...got my toes in the water....

0 · Reply

hunanddone Feb. 10 at 6:46 PM

$MEDP Gonna write the 450 calls for $15 when they get there. Bring in 15 large in income, reduce my basis to 427 and if I lose it at 450, 465 equiv with call... not a bad 10 days work.

0 · Reply

hunanddone Feb. 10 at 6:42 PM

$MEDP in for 1000 at $442.80. At 447.80 will consider taking 5 off the table however I think it closes at 458-464

0 · Reply

hunanddone Feb. 10 at 6:40 PM

$MEDP Don't get suckered out of a smart buy because of some no basis childish message board poster who quite cavalierly says....oh it could go to 390 when its already down beyond logical correction mode. Just like trees dont grow to the sky, shit doesnt funnel down to China. Especially not quality shit.

0 · Reply

hunanddone Feb. 10 at 6:22 PM

$MEDP seems overdone. Buying opp but just no volume hitting the bid so vulnerable to short trading companies who have so much money and can relentless pressure it lower. Trust me I know these orgs and you cant stand against them. You will lose

0 · Reply

AStrokeOfLuck Feb. 10 at 4:19 PM

$MEDP

0 · Reply

Arcides Feb. 10 at 4:10 PM

$MEDP clear triple top...dont ignore price action...the uptrend from july is broken now...

1 · Reply

RazorbackAJ Feb. 10 at 3:29 PM

$MEDP Already down 9% and trailing stop moved to $482 and in big profit. Follow for such precise calls with actual stop losses.

0 · Reply

Warren1989 Feb. 10 at 3:23 PM

$MEDP not sure why the big drop today. Earning were not bad.

0 · Reply

CatRocks Feb. 10 at 3:08 PM

$MEDP Still has a lingering $334 gap that might be filled.

0 · Reply

SMachi Feb. 10 at 3:05 PM

$MEDP going up I think got hit quite a bit ; let’s see 490/485

0 · Reply

OpenOutcrier Feb. 10 at 1:36 PM

$MEDP (-5.9% pre) Medpace (NASDAQ:MEDP) Releases FY 2026 Earnings Guidance https://ooc.bz/l/92688

0 · Reply

LuizRec25 Feb. 10 at 12:56 PM

$MEDP they have a support at this level, so all depends what is the call brings, if no pleasing maybe down to the next support at $420

0 · Reply

Market Cap	12.55B
Revenue (ttm)	2.53B
Net Income (ttm)	451.12M
EPS (ttm)	N/A
PE Ratio	29.08
Forward PE	26.07
Profit Margin	17.83%
Debt to Equity Ratio	0.00

Volume	372,200
Avg Vol	316,548
Day's Range	N/A - N/A
Shares Out	28.38M
Stochastic %K	71%
Beta	1.42
Analysts	Sell
Price Target	$501.27